BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24234399)

  • 1. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
    Galindo CL; Ryzhov S; Sawyer DB
    Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulin-1/ErbB signaling and chronic heart failure.
    Xu Y; Li X; Liu X; Zhou M
    Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.
    Lenneman CG
    Curr Heart Fail Rep; 2014 Jun; 11(2):134-8. PubMed ID: 24682830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of neuregulin-1 in cardiovascular disease.
    Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure.
    De Keulenaer GW; Feyen E; Dugaucquier L; Shakeri H; Shchendrygina A; Belenkov YN; Brink M; Vermeulen Z; Segers VFM
    Circ Heart Fail; 2019 Oct; 12(10):e006288. PubMed ID: 31607147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts.
    Kirabo A; Ryzhov S; Gupte M; Sengsayadeth S; Gumina RJ; Sawyer DB; Galindo CL
    J Mol Cell Cardiol; 2017 Apr; 105():59-69. PubMed ID: 28263756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin-1β induces embryonic stem cell cardiomyogenesis via ErbB3/ErbB2 receptors.
    Hao J; Galindo CL; Tran TL; Sawyer DB
    Biochem J; 2014 Mar; 458(2):335-41. PubMed ID: 24364879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
    Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
    J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.
    Wadugu B; Kühn B
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2139-47. PubMed ID: 22427524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Neuregulin-1beta/ErbB signaling in the heart.
    Pentassuglia L; Sawyer DB
    Exp Cell Res; 2009 Feb; 315(4):627-37. PubMed ID: 18801360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.
    Lemmens K; Doggen K; De Keulenaer GW
    Circulation; 2007 Aug; 116(8):954-60. PubMed ID: 17709650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells.
    Zhu WZ; Xie Y; Moyes KW; Gold JD; Askari B; Laflamme MA
    Circ Res; 2010 Sep; 107(6):776-86. PubMed ID: 20671236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure.
    Matsukawa R; Hirooka Y; Ito K; Honda N; Sunagawa K
    J Hypertens; 2014 Apr; 32(4):817-25. PubMed ID: 24406781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin in cardiovascular development and disease.
    Odiete O; Hill MF; Sawyer DB
    Circ Res; 2012 Oct; 111(10):1376-85. PubMed ID: 23104879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
    Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
    J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure.
    Galindo CL; Kasasbeh E; Murphy A; Ryzhov S; Lenihan S; Ahmad FA; Williams P; Nunnally A; Adcock J; Song Y; Harrell FE; Tran TL; Parry TJ; Iaci J; Ganguly A; Feoktistov I; Stephenson MK; Caggiano AO; Sawyer DB; Cleator JH
    J Am Heart Assoc; 2014 Oct; 3(5):e000773. PubMed ID: 25341890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling.
    Kuramochi Y; Cote GM; Guo X; Lebrasseur NK; Cui L; Liao R; Sawyer DB
    J Biol Chem; 2004 Dec; 279(49):51141-7. PubMed ID: 15385548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.
    Ky B; Kimmel SE; Safa RN; Putt ME; Sweitzer NK; Fang JC; Sawyer DB; Cappola TP
    Circulation; 2009 Jul; 120(4):310-7. PubMed ID: 19597049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes.
    Kuramochi Y; Guo X; Sawyer DB
    J Mol Cell Cardiol; 2006 Aug; 41(2):228-35. PubMed ID: 16769082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk.
    Lemmens K; Segers VF; Demolder M; De Keulenaer GW
    J Biol Chem; 2006 Jul; 281(28):19469-77. PubMed ID: 16698793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.